Articles producció científicaBioquímica i Biotecnologia

Mediterranean diet decreases the initiation of use of vitamin k epoxide reductase inhibitors and their associated cardiovascular risk: A randomized controlled trial

  • Identification data

    Identifier:  imarina:9139014
    Authors:  Castro-Barquero, Sara; Ribo-Coll, Margarita; Lassale, Camille; Tresserra-Rimbau, Anna; Castaner, Olga; Pinto, Xavier; Angel Martinez-Gonzalez, Miguel; Sorli, Jose, V; Salas-Salvado, Jordi; Lapetra, Jose; Gomez-Gracia, Enrique; Alonso-Gomez, Angel M; Fiol, Miquel; Serra-Majem, Lluis; Sacanella, Emilio; Javier Basterra-Gortari, Francisco; Portoles, Olga; Babio, Nancy; Cofan, Montserrat; Ros, Emilio; Estruch, Ramon; Hernaez, Alvaro
    Abstract:
    © 2020 by the authors. Licensee MDPI, Basel, Switzerland. Our aim is to assess whether following a Mediterranean Diet (MedDiet) decreases the risk of initiating antithrombotic therapies and the cardiovascular risk associated with its use in older individuals at high cardiovascular risk. We evaluate whether participants of the PREvención con DIeta MEDiterránea (PREDIMED) study allocated to a MedDiet enriched in extra-virgin olive oil or nuts (versus a low-fat control intervention) disclose differences in the risk of initiation of: (1) vitamin K epoxide reductase inhibitors (acenocumarol/warfarin; n = 6772); (2) acetylsalicylic acid as antiplatelet agent (n = 5662); and (3) other antiplatelet drugs (cilostazol/clopidogrel/dipyridamole/ditazol/ticlopidine/triflusal; n = 6768). We also assess whether MedDiet modifies the association between the antithrombotic drug baseline use and incident cardiovascular events. The MedDiet intervention enriched with extra-virgin olive oil decreased the risk of initiating the use of vitamin K epoxide reductase inhibitors relative to control diet (HR: 0.68 [0.46–0.998]). Their use was also more strongly associated with an increased risk of cardiovascular disease in participants not allocated to MedDiet interventions (HRcontrol diet: 4.22 [1.92–9.30], HRMedDiets: 1.71 [0.83–3.52], p-interaction = 0.052). In conclusion, in an older population at high cardiovascular risk, following a MedDiet decreases the initiation of antithrombotic therapies and the risk of suffering major cardiovascular events among users of vitamin K epoxide reductase inhibitors.
  • Others:

    Author, as appears in the article.: Castro-Barquero, Sara; Ribo-Coll, Margarita; Lassale, Camille; Tresserra-Rimbau, Anna; Castaner, Olga; Pinto, Xavier; Angel Martinez-Gonzalez, Miguel; Sorli, Jose, V; Salas-Salvado, Jordi; Lapetra, Jose; Gomez-Gracia, Enrique; Alonso-Gomez, Angel M; Fiol, Miquel; Serra-Majem, Lluis; Sacanella, Emilio; Javier Basterra-Gortari, Francisco; Portoles, Olga; Babio, Nancy; Cofan, Montserrat; Ros, Emilio; Estruch, Ramon; Hernaez, Alvaro
    Department: Bioquímica i Biotecnologia
    URV's Author/s: Babio Sánchez, Nancy Elvira / Salas Salvadó, Jorge
    Keywords: Vitamin k epoxide reductases; Time factors; Randomized controlled trials; Prevention; Platelet aggregation inhibitors; Olive oil; Nuts; Middle aged; Mediterranean diet; Male; Humans; Heart disease risk factors; Fibrinolytic agents; Female; Enzyme inhibitors; Diet, mediterranean; Diet, fat-restricted; Cardiovascular diseases; Aged; 4-hydroxycoumarins
    Abstract: © 2020 by the authors. Licensee MDPI, Basel, Switzerland. Our aim is to assess whether following a Mediterranean Diet (MedDiet) decreases the risk of initiating antithrombotic therapies and the cardiovascular risk associated with its use in older individuals at high cardiovascular risk. We evaluate whether participants of the PREvención con DIeta MEDiterránea (PREDIMED) study allocated to a MedDiet enriched in extra-virgin olive oil or nuts (versus a low-fat control intervention) disclose differences in the risk of initiation of: (1) vitamin K epoxide reductase inhibitors (acenocumarol/warfarin; n = 6772); (2) acetylsalicylic acid as antiplatelet agent (n = 5662); and (3) other antiplatelet drugs (cilostazol/clopidogrel/dipyridamole/ditazol/ticlopidine/triflusal; n = 6768). We also assess whether MedDiet modifies the association between the antithrombotic drug baseline use and incident cardiovascular events. The MedDiet intervention enriched with extra-virgin olive oil decreased the risk of initiating the use of vitamin K epoxide reductase inhibitors relative to control diet (HR: 0.68 [0.46–0.998]). Their use was also more strongly associated with an increased risk of cardiovascular disease in participants not allocated to MedDiet interventions (HRcontrol diet: 4.22 [1.92–9.30], HRMedDiets: 1.71 [0.83–3.52], p-interaction = 0.052). In conclusion, in an older population at high cardiovascular risk, following a MedDiet decreases the initiation of antithrombotic therapies and the risk of suffering major cardiovascular events among users of vitamin K epoxide reductase inhibitors.
    Thematic Areas: Zootecnia / recursos pesqueiros; Saúde coletiva; Química; Psicología; Planejamento urbano e regional / demografia; Nutrition and dietetics; Nutrition & dietetics; Nutrição; Medicina veterinaria; Medicina iii; Medicina ii; Medicina i; Interdisciplinar; Food science; Farmacia; Engenharias iv; Engenharias ii; Enfermagem; Educação física; Economia; Ciências biológicas iii; Ciências biológicas ii; Ciências biológicas i; Ciências agrárias i; Ciência de alimentos; Biotecnología
    licence for use: https://creativecommons.org/licenses/by/3.0/es/
    Author's mail: jordi.salas@urv.cat; nancy.babio@urv.cat
    Record's date: 2025-02-19
    Paper version: info:eu-repo/semantics/publishedVersion
    Link to the original source: https://www.mdpi.com/2072-6643/12/12/3895
    Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
    Paper original source: Nutrients. 12 (12): 1-14
    APA: Castro-Barquero, Sara; Ribo-Coll, Margarita; Lassale, Camille; Tresserra-Rimbau, Anna; Castaner, Olga; Pinto, Xavier; Angel Martinez-Gonzalez, Miguel; (2020). Mediterranean diet decreases the initiation of use of vitamin k epoxide reductase inhibitors and their associated cardiovascular risk: A randomized controlled trial. Nutrients, 12(12), 1-14. DOI: 10.3390/nu12123895
    Article's DOI: 10.3390/nu12123895
    Entity: Universitat Rovira i Virgili
    Journal publication year: 2020
    Publication Type: Journal Publications
  • Keywords:

    Food Science,Nutrition & Dietetics,Nutrition and Dietetics
    Vitamin k epoxide reductases
    Time factors
    Randomized controlled trials
    Prevention
    Platelet aggregation inhibitors
    Olive oil
    Nuts
    Middle aged
    Mediterranean diet
    Male
    Humans
    Heart disease risk factors
    Fibrinolytic agents
    Female
    Enzyme inhibitors
    Diet, mediterranean
    Diet, fat-restricted
    Cardiovascular diseases
    Aged
    4-hydroxycoumarins
    Zootecnia / recursos pesqueiros
    Saúde coletiva
    Química
    Psicología
    Planejamento urbano e regional / demografia
    Nutrition and dietetics
    Nutrition & dietetics
    Nutrição
    Medicina veterinaria
    Medicina iii
    Medicina ii
    Medicina i
    Interdisciplinar
    Food science
    Farmacia
    Engenharias iv
    Engenharias ii
    Enfermagem
    Educação física
    Economia
    Ciências biológicas iii
    Ciências biológicas ii
    Ciências biológicas i
    Ciências agrárias i
    Ciência de alimentos
    Biotecnología
  • Documents:

  • Cerca a google

    Search to google scholar